Select | PubMed ID | Description |
| 15100313 | J Immunol. 2004 May 1;172(9):5684-92.
Generation of an allergy vaccine by disruption of the three-dimensional structure of the cross-reactive calcium-binding allergen, Phl p 7.
Westritschnig K(1), Focke M, Verdino P, Goessler W, Keller W, Twardosz A, Mari A, Horak F, Wiedermann U, Hartl A, Thalhamer J, Sperr WR, Valent P, Valenta R.
|
| 18289680 | Mol Immunol. 2008 May;45(9):2465-73. doi: 10.1016/j.molimm.2008.01.009. Epub 2008 Mar 4.
Isolation, expression and immunological characterization of a calcium-binding protein from Parietaria pollen.
Bonura A(1), Gulino L, Trapani A, Di Felice G, Tinghino R, Amoroso S, Geraci D, Valenta R, Westritschnig K, Scala E, Mari A, Colombo P.
|
| 18564332 | Clin Exp Allergy. 2008 Aug;38(8):1400-8. doi: 10.1111/j.1365-2222.2008.03031.x. Epub 2008 Jun 28.
Heterogeneity of commercial timothy grass pollen extracts.
Focke M(1), Marth K, Flicker S, Valenta R.
|
| 20817878 | J Immunol. 2010 Oct 1;185(7):4199-205. doi: 10.4049/jimmunol.0902249. Epub 2010 Sep 3.
A protein's conformational stability is an immunologically dominant factor: evidence that free-energy barriers for protein unfolding limit the immunogenicity of foreign proteins.
Ohkuri T(1), Nagatomo S, Oda K, So T, Imoto T, Ueda T.
|
| 27238577 | Ann Allergy Asthma Immunol. 2016 Aug;117(2):180-5. doi: 1016/j.anai.2016.05.010. Epub 2016 May 27.
Detection of pan-allergens in commercial pollen extracts for allergen immunotherapy.
Asero R(1), Mistrello G(2), Amato S(2).
|
| 31127132 | Sci Rep. 2019 May 24;9(1):7802. doi: 10.1038/s41598-019-44208-0.
Rational design of a hypoallergenic Phl p 7 variant for immunotherapy of polcalcin-sensitized patients.
Raith M(1), Zach D(1), Sonnleitner L(2), Woroszylo K(1), Focke-Tejkl M(3), Wank H(1), Graf T(4), Kuehn A(4), Pascal M(5), Muņoz-Cano RM(6), Wortmann J(7), Aschauer P(7), Keller W(7), Braeuer S(8), Goessler W(8), Swoboda I(9).
|
| 32375962 | Allergy Asthma Proc. 2020 May 1;41(3):183-191. doi: 10.2500/aap.2020.41.200002.
Serum immunoglobulin E reactivity to cross-reacting panallergen components in north-eastern Poland patients pollen sensitized.
Kowal K(1), Pampuch A(2), Sacharzewska E(1), Swiebocka E(3), Siergiejko Z(4), Siergiejko G(5), Chruszcz M(6), DuBuske L(7).
|